"Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ(R) (lorcaserin HCl) for Chronic Weight Management
-- Arena to Receive $65 Million in Milestone Payments from Eisai --
SAN DIEGO , May 7, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing BELVIQ (pronounced BEL-VEEK) into Schedule IV of the Controlled Substances Act. The scheduling designation will be effective 30 days after tomorrow's expected publication in the Federal Register . Following the effective date, BELVIQ will be available to patients in the United States by prescription, and Arena will receive $65 million in milestone payments from Eisai Inc. under their marketing and supply agreement."
It's called logical inference. You're just trying to argue a technicality. I bet you're a republican. You argue just like one. Probably tea party, too
Well, gee, one side exhibited a 50% reduction in CTGF production "THAT AIN'T RANDOM"
That's true, but perhaps it can gap up tomorrow if good news comes out. I wouldn't put too much expectation on conference news, though. It rarely does much to pps. However, this conf. is with potential investors, so $ might start flowing in from them after conf.
Mid-April, generally 45 days after Q(1) closes:
Why did you write YOU as an acronym? Did you fail basic English or are you really THAT S.T.U.P.I.D.?